国药集团昆明血液制品有限公司(简称“昆明血制”)于2022年10月27日在云南昆明注册成立,是国药集团上海血液制品有限公司(简称“上海血制”)整体搬迁至云南滇中新区新建的血液制品生产研发企业,属于“央企入滇 沪滇合作”示范项目,属于生物医药范畴,总投资16.55亿元(不含云南省配套单采血浆站),设计投浆量1,200吨/年。昆明血制作为血液制品生产企业,其生产范围为人血白蛋白、人免疫球蛋白、凝血因子三大类,共10个品种18个规格。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows